Trends in mortality due to myeloid leukemia in regions of Brazil and the country as a whole between 1980 and 2012
نویسندگان
چکیده
Letter to the Editor Trends in mortality due to myeloid leukemia in regions of Brazil and the country as a whole between 1980 and 2012 Dear Editor, We read with great interest the article entitled " Trends in mortality of adult patients diagnosed with myeloid leukemia from 1994 to 2011 in southeastern Brazil " by Callera et al. published in the Revista Brasileira de Hematologia e Hemoterapia (2015;37(1):7–11), 1 and we would like to make some comments. The subject of the article is very important for clinical oncology and cancer surveillance as it presents a time series analysis showing a declining trend in mortality from myeloid leukemia in one area of the richest region of Brazil. It is understood that this decline is a result of the improving quality of access to health services with early diagnosis of the disease and clinical management. However, Brazil is the size of a continental and, therefore, we believe it is important to observe the trend of mortality due to myeloid leukemia in other regions of Brazil and the country as a whole. In 2014, the Brazilian National Cancer Institute estimated the incidence of leukemia in Brazil to be around 5050 and 4320 new cases for men and women, respectively. Excluding non-melanoma skin tumors, leukemia is the fifth most common cancer in men in the Northern Region of the it is the eleventh most frequent. 2 This inconsistency has been observed worldwide. GLOBO-CAN estimates the global prevalence of leukemia to be 4.7/100,000 inhabitants. The same report shows, however, that there are differences in the rates when comparing medium (3.8/100,000) and under (2.5/100,000) developed countries. With regard to mortality, the global estimate is 3.4/100,000 inhabitants, 3.2/100,000 for medium and 2.4/100,000 for under development countries. 3 By using a methodology 4 similar to Callera et al., 1 we identified important differences in different Brazilian regions. Myeloid leukemia mortality rates between 1980 and 2012 are different when stratified by gender. The rates in men are which may point to important differences between the genders. In addition, the rates are consistently higher in the Southeast and South, regardless of gender, which shows regional differences in the impact of the disease (Figure 1). Regarding the trend, there is a difference related to gender and region. For males, there was a significant increase in the incidence rates in Brazil between 1980 and 2005. After 2005, there was a statistically non-significant …
منابع مشابه
Association between Urban Benzene Pollution and Incidence of Acute Myeloid Leukemia
Background: Benzene has been classified as group 1 human carcinogens in the environment by the International Agency for Research on Cancer (IARC) mainly because of its ability to cause acute myeloid leukemia (AML). This study was conducted to detect any probable association between urban benzene pollution concentration and occurrence of AML in different regions of Tehran. Methods: In thi...
متن کاملRegional climate change scenarios and their impacts on water requirements for wheat production in Iran
We simulate the effect of climate change on water requirements of cold seasonwheat in various climatic zones of Iran. The research considers both observedclimate (temperature and precipitation) changes during recent decades (1960-2009)based on instrumental records and projected future changes to 2100 based on theMAGICC/SCENGEN 5.3 compound model. 20 General Circulation models are usedbased on a...
متن کاملQuality of Life of Patients with Different Types of Leukemia
Background: Leukemia is one of the major causes of mortality and disability and the seventh most prevalent cancer worldwide. It has various effects on different aspects of physical, psychological, reproductive, social, and economic performance of human life. This study compared the quality of life of patients with different types of leukemia hospitalized in Ayatollah Khansari Hospital in Arak- ...
متن کاملTreatment of a Child with Refractory Acute Myeloid Leukemia with Humanized Anti-CD33 Monoclonal Antibody: A Case Report and Review of Drug Development
Background: The induction chemotherapy regimen for acute myeloid leukemia has evolved as once induction is completed patients progress through the consolidation phase and achieve remission in 76% of cases. For patients with relapsed or refractory disease, alternative chemotherapy agents are available. Monoclonal antibody therapy with biological agents, such as the immunotoxin gemtuzumab ozog...
متن کاملUnilateral Ptosis as Initial Manifestation of Acute Myeloid Leukemia
Abstract Background In Acute Myeloid Leukemia (AML), malignant clones of immature myeloid cells (primarily blasts) proliferate, replace bone marrow, circulate in blood and invade other tissues. The unique presentation of unilateral ptosis and unilateral eyelid swelling in AML has been reported during the present study. Case Report A 7-year-old girl was encountered with progressively increa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 38 شماره
صفحات -
تاریخ انتشار 2016